These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [The estimation of LHRH receptors in the tissue of human leiomyoma, myometrium and endometrium]. Marinaccio M; Reshkin S; Pinto V; Paradiso A Minerva Ginecol; 1994 Oct; 46(10):519-26. PubMed ID: 7838406 [TBL] [Abstract][Full Text] [Related]
48. Review of the evidence for treatment of leiomyomata. Olive DL Environ Health Perspect; 2000 Oct; 108 Suppl 5():841-3. PubMed ID: 11035992 [TBL] [Abstract][Full Text] [Related]
49. Clinical decision making regarding leiomyomata: what we need in the next millenium. Haney AF Environ Health Perspect; 2000 Oct; 108 Suppl 5():835-9. PubMed ID: 11035991 [TBL] [Abstract][Full Text] [Related]
53. [Surgical treatment of subserosal fibroids: the cons]. Marret H; Ouldamer L Gynecol Obstet Fertil; 2011; 39(7-8):454-7. PubMed ID: 21752689 [No Abstract] [Full Text] [Related]
54. [Pulmonary densities following a hysterectomy, caused by benign metastatic leiomyoma]. Scheer ML; Slebos DJ; Bogchelman DH; Timens W Ned Tijdschr Geneeskd; 2008 Sep; 152(37):2027-31. PubMed ID: 18825892 [TBL] [Abstract][Full Text] [Related]
55. Effect of gonadotropin-releasing hormone agonist treatment upon angiogenesis in uterine leiomyoma. Abulafia O; Kleinhaus K; Levi G; Lee YC; Sherer DM Gynecol Obstet Invest; 2001; 52(2):108-13. PubMed ID: 11586038 [TBL] [Abstract][Full Text] [Related]
56. Medical and socioeconomic impact of uterine fibroids. Greenberg MD; Kazamel TI Obstet Gynecol Clin North Am; 1995 Dec; 22(4):625-36. PubMed ID: 8786874 [No Abstract] [Full Text] [Related]
57. [Effect of GnRH analogues pre-treatment on myomectomy outcomes in reproductive age women]. Hudecek R; Ivanová Z; Smerdová M; Pánková S; Krajcovicová R Ceska Gynekol; 2012 Apr; 77(2):109-17. PubMed ID: 22702067 [TBL] [Abstract][Full Text] [Related]
58. New approaches to the management of fibroids. Olive DL Obstet Gynecol Clin North Am; 2000 Sep; 27(3):669-75. PubMed ID: 10958011 [TBL] [Abstract][Full Text] [Related]
59. Treatment of uterine leiomyomata by LH-RH agonists. Blumenfeld Z Recent Results Cancer Res; 1992; 124():19-31. PubMed ID: 1615216 [No Abstract] [Full Text] [Related]
60. ACOG criteria set. Gonadotropin-releasing hormone agonists for preoperative treatment of leiomyomata. American College of Obstetricians and Gynecologists Committee on Quality Assessment. Int J Gynaecol Obstet; 1996 Feb; 52(2):213-4. PubMed ID: 8855113 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]